Alberto Palacios Cañas

Mr. Alberto Palacios Cañas

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MIMARIA ARANZAZU MARTIN IGLESIAS
MARIA ARANZAZU MARTIN IGLESIAS
RRRosa Garcia Rodriguez
Rosa Garcia Rodriguez
ACAlberto Palacios Cañas
Alberto Palacios Cañas
JSJaime Vinicio Meneses Sotomayor
Jaime Vinicio Meneses Sotomayor
MCMiriam Clar Castello
Miriam Clar Castello
FFFrancisco J. Feo-Brito
Francisco J. Feo-Brito
Introduction: SLIT for the treatment of plant food allergies has been demonstrated to be safe but less effective than OIT, but the latter is associated with more adverse reactions. The aim of the study was to evaluate the efficacy and safety of a new protocol starting with SLIT-peach followed by OIT with commercial peach juice in patients with LTP syndrome. Methods: This was a prospective, noncontrolled, open study on patients with LTP syndrome who are not sensitized to storage proteins. SLIT peach ALK was followed by OIT with Granini® peach juice after 40 days of the SLIT maintenance phase. At home, the Granini® juice dose was progressively increased during the 42 days until reaching 200 ml. After achieving the maximum dose, an open oral food challenge was carried out with the food that had caused the most severe reaction. If negative, the patient was instructed to progressively introduce the foods that were avoided before starting immunotherapy at home. Patients were reviewed 1 month later. The quality-of-life questionnaire FAQLQ-AF was completed at the beginning of the study and one month after the final challenge. Results: Forty-five patients were included, most of them with LTP anaphylaxis. Peach SLIT was well tolerated in 80.5%, and OIT with Granini® was well tolerated in 85%, with no severe adverse reactions. The final provocation was successful in 39/45 (86.6%). One month after the final provocation, 42/45 (93.3%) patients had no dietary restrictions. FAQLA-AF was significantly reduced. Conclusions: This combination of peach SLIT and OIT with commercial peach juice provides a new, fast, effective, and safe immunotherapy option for selected patients with LTP syndrome who are not allergic to storage proteins, improving their quality of life. This study suggests that cross-desensitization relative to the nsLTPs of several plant foods can be achieved by using Prup3.

4 December 2020 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
ETElisa Gómez Torrijos
Elisa Gómez Torrijos
MAMónica Garcia Arpa
Mónica Garcia Arpa
AGAlejandro Raúl Gratacós Gómez
Alejandro Raúl Gratacós Gómez
MVMaria Rogel Vence
Maria Rogel Vence
APAna Rojas Parra
Ana Rojas Parra
ACAlberto Palacios Cañas
Alberto Palacios Cañas

27 July 2021 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
AGAlejandro Raúl Gratacós Gómez
Alejandro Raúl Gratacós Gómez
OJOscar Gonzalez jimenez
Oscar Gonzalez jimenez
ACAlberto Palacios Cañas
Alberto Palacios Cañas
LLLucia Moreno Lozano
Lucia Moreno Lozano
MCMiguel Juan Cencerrado
Miguel Juan Cencerrado
ETElisa Gómez Torrijos
Elisa Gómez Torrijos

18 November 2021 in Contact Dermatitis
Verified
Journal Article
Closed access
PDF file
AGAlejandro Raúl Gratacós Gómez
Alejandro Raúl Gratacós Gómez
JRJuana Bautista Joyanes Romo
Juana Bautista Joyanes Romo
JSJaime Vinicio Meneses Sotomayor
Jaime Vinicio Meneses Sotomayor
OJOscar Gonzalez jimenez
Oscar Gonzalez jimenez
ACAlberto Palacios Cañas
Alberto Palacios Cañas
ETElisa Gómez Torrijos
Elisa Gómez Torrijos

21 August 2023 in Revista Alergia México
Verified
Journal Article
Open access
PDF file
ACAlberto Palacios Cañas
Alberto Palacios Cañas
JSJaime Vinicio Meneses Sotomayor
Jaime Vinicio Meneses Sotomayor
MCMíriam Clar Castelló
Míriam Clar Castelló
ETElisa Gómez Torrijos
Elisa Gómez Torrijos
JSJesús María Borja Segade
Jesús María Borja Segade
RRRosa García Rodríguez
Rosa García Rodríguez
Background Diagnosis of drug hypersensitivity bases on detailed clinical history and skin and challenge tests, which may involve an unaffordable risk. Knowing the reproducibility of reactions could help on the decision of performing them according to safety criteria. Objective The aim was to assess the reproducibility of symptoms in drug challenge tests. Methods The study included patients with positive cutaneous or challenge test throughout 2019. For each patient, clinical suspicion according to Karch-Lasagna algorithm was registered. Primary outcome was the reproducibility of symptoms in the provocation tests using a paired analysis of data with McNemar test. Results Eighty nine patients were included, 16 of them presented more than one positive test. Thirty were skin tests positive and 75 reacted to provocation tests. Eighty nine percent of patients who reacted in challenge test were probably or possibly reactors according to Karch-Lasagna scale. Symptoms of initial reaction did not differ from those triggered in challenge tests. Conclusions Karch-Lasagna scale is useful in predicting the response to drug provocation tests. In most of the positive studies, results were suggested by clinical history and no differences were found between symptoms triggered in challenge test and that referred to in the previous reaction.